SMS Lifesciences India Limited reported earnings results for the third quarter and nine months ended December 31, 2022. For the third quarter, the company reported sales was INR 882.93 million compared to INR 910.59 million a year ago. Revenue was INR 887.96 million compared to INR 910.94 million a year ago. Net income was INR 39.86 million compared to INR 23.29 million a year ago. Basic earnings per share from continuing operations was INR 13.18 compared to INR 7.7 a year ago.
For the nine months, sales was INR 2,518.29 million compared to INR 2,540.8 million a year ago. Revenue was INR 2,523.35 million compared to INR 2,544.32 million a year ago. Net income was INR 97.46 million compared to INR 162.09 million a year ago. Basic earnings per share from continuing operations was INR 32.24 compared to INR 53.61 a year ago.